Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. JDOC: which is better?

Bottom line

XLV vs JDOC: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 62% by weight.

XLV is cheaper at 0.08% vs 0.65% — a difference of $57 a year per $10,000 invested.

Over one year, JDOC returned +14.9% vs +14.5% for XLV.

Updated Nov 19, 2026

XLV vs JDOC side by side

XLVJDOC
TypeETFETF
Fund familySPDR (State Street)J.P. Morgan
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.65%
Annual cost per $10k$8$65
10-yr cost on $10k (prospectus)$103$810
Max front loadNoneNone
12b-1 fee0.02%—
1-yr return+14.5%+14.9%
5-yr return (annualized)+8.1%—
10-yr return (annualized)+9.8%—
Best quarter+14.5%+11.3%
Worst quarter−12.7%−11.9%
Net assets (fund)$40.6B$9.1M
Number of holdings6561
Portfolio turnover2%92%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVJDOCDifference
2025+14.5%+14.9%−0.4%
2024+2.5%−0.6%+3.1%

Source: Fund prospectus bar charts

Holdings overlap

15 of XLV's top 25 holdings also appear in JDOC's top 25.

Shared top holdings
HoldingXLVJDOC
Eli Lilly & Co16.51%7.76%
Johnson & Johnson10.64%4.82%
AbbVie Inc7.74%7.85%
UnitedHealth Group Inc6.57%5.85%
Merck & Co Inc5.52%4.82%
Thermo Fisher Scientific Inc3.24%3.73%
Abbott Laboratories2.75%3.11%
Intuitive Surgical Inc2.45%1.93%
CVS Health Corp2.30%2.83%
Danaher Corp2.09%2.16%
Bristol-Myers Squibb Co2.05%3.57%
Stryker Corp1.89%2.23%
Regeneron Pharmaceuticals Inc1.08%1.60%
Cardinal Health Inc0.97%1.51%
Cencora Inc0.96%2.07%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

FAQ

What is the difference between XLV and JDOC?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 62% by weight. XLV is cheaper at 0.08% vs 0.65% — a difference of $57 a year per $10,000 invested.
Which is cheaper, XLV or JDOC?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and JDOC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.